Cited by 102Menopause: Health Impacts and TreatmentsOvarian function and disordersEstrogen and related hormone effects

Estrogen deprivation and cardiovascular disease risk in primary ovarian insufficiency

Open access
Christ, Jacob P., Gunning, Marlise N., Palla, Giulia, Eijkemans, Marinus J.C., Lambalk, Cornelis B., Laven, Joop S.E., Fauser, Bart C.J.M.·2018·Fertility and Sterility

Abstract

Objective To evaluate the association between estrogen (E) exposure and deficiency and cardiovascular disease (CVD) risk among women with primary ovarian insufficiency (POI).Design Cross-sectional study conducted between 1996 and 2016.Setting Tertiary referral centers.Patient(s) A total of 385 women with POI, defined by amenorrhea and FSH levels ≥40 IU/L before 40 years of age, were recruited.Intervention(s) None.Main outcome measure(s) Women underwent a standardized intake questionnaire including data on menstrual cyclicity. Lifetime E exposure and E-free period were assessed. Serum was analyzed for endocrine and CVD profiles. The Framingham 30-year risk of CVD was calculated.Result(s) Lifetime E exposure (mean ± SD) was 19.3 ± 7.0 years, E-free period was 3.1 ± 4.1 years, and age at screening was 34.8 ± 7.4 years. In multivariate models E-free interval associated positively with estimated risk of hard and general CVD events (β 0.18 [95% confidence interval 0.08, 0.29]; 0.20 [0.05, 0.35], respectively), and lifetime E exposure associated negatively with estimated risk of hard and general CVD events (-0.15 [-0.24, -0.05]; -0.16 [-0.29, -0.03], respectively), as well as low density lipoprotein cholesterol (-0.03 [-0.06, 0.00]) and non-high density lipoprotein cholesterol (-0.04 [-0.07, 0.00]).Conclusion(s) Prolonged E deprivation is associated with an increased estimated risk of CVD, whereas prolonged E exposure is associated with a reduced estimated risk. These results support the policy of early and continued use of E replacement therapy in women with POI.Clinical trial registration number NCT0230904.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.fertnstert.2017.11.035

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Christ, J. P., Gunning, M. N., Palla, G., Eijkemans, M. J. C., Lambalk, C. B., Laven, J. S. E., & Fauser, B. C. J. M.
Affiliations
  • University Medical Center Utrecht (NL)
  • University of Pisa (IT)
  • Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)
  • Erasmus MC (NL)
Corresponding author
Christ, Jacob P.
Venue
Fertility and Sterility
Publisher
Elsevier BV
Published
2018-04
Volume
109
Issue
4
Pages
594-600.e1
ISSN
0015-0282 (ISSN-L)
OpenAlex
W2794655584
Cited by
102
References
27
Citations by year
2026: 8 · 2025: 7 · 2024: 8 · 2023: 7 · 2022: 33 · 2021: 10 · 2020: 12 · 2019: 13 · 2018: 4
FWCI
7.75
Type
journal article
Language
en
Open access
Locations
  • Fertility and Sterility (publishedVersion)
  • PubMed (publishedVersion)
  • Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
  • EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
  • Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
  • Pure Amsterdam UMC (submittedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
Funders
Danone
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
  • Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Estrogen and related hormone effects
Keywords
primary ovarian insufficiency, estrogen deprivation, cardiovascular risk, estrogen replacement therapy, lipid profile, LDL cholesterol, non-HDL cholesterol
MeSH terms
Adult, Cardiovascular Diseases, Cross-Sectional Studies, Estradiol, Female, Humans, Netherlands, Prognosis, Risk Factors, Time Factors, Biomarkers, Estrogen Replacement Therapy, Primary Ovarian Insufficiency, Risk Assessment, Protective Factors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review